Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, September 15 2014 8:59pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drug Manufacturers - Major
Composite Value: 1217.2
Today's Change: +0.19%
S&P 500: -0.07%
chart for
[Drug Manufacturers - Major (^YHOh783)]
Drug Manufacturers - Major News
Lawyer grills DePuy executive over safety studies for Pinnacle hips
34 minutes ago (Reuters)
An executive at Johnson & Johnson's DePuy Orthopaedics Inc unit on Monday defended the company's assessment of safety risks associated with metal-on-metal Pinnacle hip implants in a Dallas court from a lawyer who said the company had neglected to perform critical safety testing. Pamela Plouhar, the worldwide vice president of clinical research at DePuy, was grilled by a lawyer for plaintiff Kathy Herlihy-Paoli during the first trial among more than 6,000 lawsuits over the Pinnacle hips that have been consolidated in Dallas federal court. On Monday, Herlihy-Paoli's lawyer, Mark Lanier, pressed Plouhar over what studies DePuy had performed on the implants, in an attempt to show jurors that the company had been negligent in gathering clinical data on the devices before they were approved by the U.S. Plouhar said there was "no human study that looked at" the health effects of metal debris for the Pinnacle hips before 2001.
ZS Pharma Presents New Data From ZS003 a Two Week Phase 3 Trial Demonstrating That ZS-9 Prevented Recurrence of Hyperkalemia in Heart Failure Patients on RAASi - (GlobeNewswire)
Merck osteoporosis drug passes trial, but side effects hover - (Reuters)
More News on Drug Manufacturers - Major: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
GLAXOSMITHKLINE [GSK.L] -0.62% $6922.6 B
ASTRAZENECA [AZN.L] +0.51% $5711.3 B
JOHNSON & JOHNSON [JNJ.MX] +0.43% $3901.9 B
NOVARTIS SP ADR [NVSN.MX] -0.61% $3004.6 B
ROCHE HLDG SP ADR [RHHBYN.MX] +1.15% $2979.9 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
09/18/14 SPH.L Preliminary 2014 Sinclair IS Pharma PLC Earnings Release
09/22/14 AGY.L Full Year 2014 Allergy Therapeutics PLC Earnings Release
10/22/14 GSK.L GlaxoSmithKline PLC Q3 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/25/14 BAY.MI BAYER N downside earnings surprise (-4.97%)
08/15/14 ICPT Intercept Pharmaceuticals, Inc. coverage initiated by FBR Capital
08/14/14 CIPLA.NS CIPLA NPP101299 DEPO downside earnings surprise (-17.73%)
More Recent Events...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
www.OmegaStatistics.com
Clinical Trial Initiation
Accelerate clinical trial start-up, site selection, and recruitment.
www.ePharmaSolutions.com
0prah Wrinkle System - $5
1 Woman Loses 94% of Wrinkles with 0prah's New Wrinkle Cream that Works
antiagingworld.org/AntiAgingCreams
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:34,149B
Price / Earnings:21.6
Price / Book:28.5
Net Profit Margin (mrq):20.8%
Price To Free Cash Flow (mrq):-369.3
Return on Equity:21.1%
Total Debt / Equity:97.2
Dividend Yield:3.5%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
GSK
SGP
BDSI
Unusually Active Boards
Board Variance
BDSI
SGP
JNJ

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?